Two weeks on Mounjaro: what's actually happening in your body?

Why do I feel sick in the first two weeks, and will it pass?

The most common question our prescribers hear in the early weeks is some version of: "Is the nausea normal, and is it going to last?" The short answer is yes, it is normal, and for the large majority of people it does ease.

Mounjaro works by activating two gut-hormone receptors (GIP and GLP-1) that are involved in appetite signalling and the speed at which your stomach empties. Slowing gastric emptying is part of what makes the medicine effective, but it is also what causes that heavy, unsettled feeling after eating in the early days. Your digestive system is adapting to a new signal it has not encountered before.

Side effects reported in clinical trials and listed by the NHS medicines page for tirzepatide include nausea, vomiting, diarrhoea, constipation, indigestion, burping, and stomach discomfort. Most of these are described as mild to moderate and tend to be worst in the first week after starting or after a dose increase. Eating smaller portions, avoiding fatty or rich food, and staying well hydrated all help. If symptoms are severe or persistent, your prescriber needs to know before any dose change is considered.

There is a misconception that floats around online: that the side effects mean the medicine is not working, or conversely, that if you feel fine you must be doing something wrong. Neither is true. Tolerance varies considerably between individuals, and a smooth first two weeks is not a bad sign.

What weight changes are realistic after two weeks on Mounjaro?

Honesty matters here. At two weeks, on 2.5 mg, most people have lost little or nothing on the scale, and that is not a reason for concern. The starter dose is intentionally low. Its purpose is adjustment, not treatment at full effect. Some people notice a small drop in body weight simply because appetite has reduced and they are eating less; others see no change at all. Both are within the normal range.

The SURMOUNT-1 trial published in the New England Journal of Medicine found that participants taking the highest dose achieved around 20–21% average weight loss over 72 weeks. That is a year and a half of titration and maintenance, not a fortnight. Weight loss on tirzepatide is a gradual process. The clinical evidence is compelling, but it reflects the full course of treatment.

Appetite change is usually the first thing people notice, often before the scales show anything. Meals that previously felt unremarkable now feel like enough. That shift in hunger signalling is real and meaningful, and it tends to become more pronounced as the dose increases over subsequent months. If you are curious about what progress typically looks like a little further along, you can read about what three weeks on Mounjaro is commonly like before the picture at six weeks on Mounjaro, which is usually more representative of early therapeutic effect.

Should I be worried if my symptoms are stronger than I expected?

For most people, two weeks in feels manageable if not entirely comfortable. Mild nausea, some fatigue, reduced appetite, and occasional loose stools are par for the course. What warrants prompt medical attention is something different in character: severe, persistent abdominal pain (particularly pain that radiates toward your back) can in rare cases indicate acute pancreatitis, which the MHRA highlighted as a known but infrequent risk in a Drug Safety Update in January 2026. Do not wait to see whether it passes. Get help the same day.

Signs of dehydration from prolonged vomiting or diarrhoea (dizziness, dark urine, inability to keep fluids down) also need medical attention rather than management at home. Allergic reactions are rare but possible; rash, swelling around the face, or difficulty breathing are reasons to call 999.

If you have questions that fall short of those thresholds (appetite changes you were not expecting, uncertainty about what to eat, whether a particular symptom is worth mentioning) that is exactly what prescriber aftercare is for. You should not have to guess. At nume, aftercare is available seven days a week; our contact page has the details.

It is also worth knowing that you can report any suspected side effect directly to the MHRA via the Yellow Card scheme, you do not need a GP to do this on your behalf.

What happens at week four, and when does titration start?

At the end of your first four-week pen, a prescriber reviews your progress before any repeat is issued. That review is not a formality. It considers how you tolerated the starter dose, whether there are any reasons to stay at 2.5 mg a little longer, and whether it is appropriate to move to 5 mg. The titration schedule is individual, not automatic.

For most people who tolerate the first pen well, 5 mg begins at week five. That is when many people notice a more pronounced effect on appetite and, a few weeks later, a clearer trend on the scales. The full picture of how weight loss evolves through the titration schedule is worth understanding before you start, our Mounjaro overview covers the licensed dose range and what the clinical evidence says at each stage. You can also read about tirzepatide in more depth if you want to understand the mechanism behind the medicine, including details on the 10ml tirzepatide format that some patients are prescribed as they progress through treatment.

If you are approaching the end of your second pen and wondering what four weeks of treatment typically looks like, the four weeks on Mounjaro page goes into that in detail. And if you are considering starting treatment and want to understand the process, our treatment overview explains your options.